कृपया अन्य खोज का प्रयास करें
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Anne-Marie Graffin | 60 | 2013 | Independent Vice Chairman of the Supervisory Board |
Gary M. Phillips | 56 | 2021 | Independent Chairman of Supervisory board |
Enno Spillner | 53 | 2014 | Independent Member of Supervisory Board |
Alain Herrera | 74 | 2013 | Independent Member of Supervisory Board |
Chiaojung Jillian Tsai | - | 2022 | Member of Scientific Advisory Board |
Stephane Champiat | - | 2022 | Member of Scientific Advisory Board |
Jared Marc Weiss | - | 2022 | Member of Scientific Advisory Board |
Christophe Le Tourneau | - | 2022 | Member of Scientific Advisory Board |
Kevin Harrington | - | - | Member of Scientific Advisory Board |
Thierry De Baere | - | 2022 | Member of Scientific Advisory Board |
Leonard A. Farber | - | 2022 | Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board |
Jean Bourhis | - | 2022 | Member of Scientific Advisory Board |
Nancy Y. Lee | - | 2022 | Member of Scientific Advisory Board |
Hisham Mehanna | - | 2022 | Member of Scientific Advisory Board |
Sylvie Bonvalot | - | 2022 | Member of Scientific Advisory Board |
Silvia Chiara Formenti | - | 2022 | Member of Scientific Advisory Board |
Robert L. Ferris | - | 2022 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है